Environmental exposure to pyrethroids and sperm sex chromosome disomy: a cross-sectional study by Young, Heather A et al.
Young et al. Environmental Health 2013, 12:111
http://www.ehjournal.net/content/12/1/111RESEARCH Open AccessEnvironmental exposure to pyrethroids and sperm
sex chromosome disomy: a cross-sectional study
Heather A Young1, John D Meeker2, Sheena E Martenies3, Zaida I Figueroa3, Dana Boyd Barr4 and Melissa J Perry3*Abstract
Background: The role of environmental pesticide exposures, such as pyrethroids, and their relationship to sperm
abnormalities are not well understood. This study investigated whether environmental exposure to pyrethroids was
associated with altered frequency of sperm sex chromosome disomy in adult men.
Methods: A sample of 75 subjects recruited through a Massachusetts infertility clinic provided urine and semen
samples. Individual exposures were measured as urinary concentrations of three pyrethroid metabolites
((3-phenoxybenzoic acid (3PBA), cis- and trans- 3-(2,2-Dichlorovinyl)-1-methylcyclopropane-1,2-dicarboxylic acid
(CDCCA and TDCCA)). Multiprobe fluorescence in situ hybridization for chromosomes X, Y, and 18 was used to
determine XX, YY, XY, 1818, and total sex chromosome disomy in sperm nuclei. Poisson regression analysis was used
to examine the association between aneuploidy rates and pyrethroid metabolites while adjusting for covariates.
Results: Between 25-56% of the sample were above the limit of detection (LOD) for the pyrethroid metabolites. All sex
chromosome disomies were increased by 7-30% when comparing men with CDCCA and TDCCA levels above the LOD
to those below the LOD. For 3PBA, compared to those below the LOD, those above the LOD had YY18 disomy rates
1.28 times higher (95% CI: 1.15, 1.42) whereas a reduced rate was seen for XY18 and total disomy (IRR = 0.82; 95% CI:
0.77, 0.87; IRR = 0.93; 95% CI: 0.87-0.97), and no association was seen for XX18 and 1818.
Conclusions: Our findings suggest that urinary concentrations of CDCCA and TDCCA above the LOD were associated
with increased rates of aneuploidy. However the findings for 3BPA were not consistent. This is the first study to
examine these relationships, and replication of our findings is needed before the association between pyrethroid
metabolites and aneuploidy can be fully defined.
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Sperm aneuploidy is a determinant factor of numerous
reproductive problems, including infertility, congenital
abnormalities, and pregnancy loss [1,2] and aneuploidy
is estimated to affect approximately 5% of clinically rec-
ognized pregnancies and 0.3% of live births [1]. Aneu-
ploidy results from the failure of chromosome pairs to
separate properly during cell division. Toxicants may ad-
versely affect germ cell DNA integrity [3]; however, the
exact causes of aneuploidy are not well understood. A
limited number of studies have identified risk factors for
sperm aneuploidy, including chemotherapy [4], smoking* Correspondence: mperry@gwu.edu
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stated.[5], and increasing paternal age [6]. Sex chromosomes
are particularly susceptible to aneuploidy and sperm that
are sex chromosome aneuploid are viable and can result
in offspring with fertility conditions such as Klinefelter
Syndrome, Turner Syndrome [1,7-9].
Chemicals such as pesticides are known to disrupt hor-
mone signaling that may interfere with recombination se-
quences [10], and prior epidemiologic studies have shown
associations between occupational pesticide use and sperm
aneuploidy (reviewed in 11). Pyrethroids (PYRs), a family
of synthetic insecticides which are structurally based on
the natural pesticide pyrethrum [11], have been identified
as potential endocrine disruptors [10,12-14].
PYRs are the most frequently used home and garden
insecticides in the United States, where an estimated 240
million applications of PYRs are made annually [15].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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larly vegetables and fruits, is the primary route of expo-
sure in the US population [16]. Urinary metabolites of
PYRs have been measured in a substantial proportion of
the general population [17]. Despite wide scale use and
human exposure, relatively little is known about the hu-
man reproductive health effects of environmental expo-
sure to PYRs [16].
Although research findings have demonstrated the po-
tential for adverse effects of PYRs on semen parameters
and sperm DNA damage [18-23], the relationship between
environmental exposure to PYRs and disomy in human
sperm has not been investigated previously.
This study sought to investigate whether environmental
exposure to PYRs was associated with altered frequency of
sperm sex chromosome disomy among adult men.
Methods
Study subjects
Study subjects were a subset of 75 men from a parent
study of 341 men assessing the impact of environmental
exposures on semen quality. In the parent study, men
aged 20–54 from couples seeking infertility evaluation at
Massachusetts General Hospital (MGH) Fertility Center
between January 2000 and May 2003 were eligible for in-
clusion. Approximately 65% of eligible men agreed to
participate, and those declining participation primarily
cited lack of time during their clinic visit as the reason
for non-participation. Men who were presenting for post-
vasectomy semen analysis and/or receiving treatment for
infertility were excluded from the parent study. None of
the men reported occupational exposure to pesticides or
other agents known to be associated with semen quality.
All participants also completed a self-administered ques-
tionnaire which collected demographic information, life-
style factors, and medical and fertility history. Full details
of the parent study have been described elsewhere [24].
Study participants provided urine and semen samples on
the same day. As samples from the parent study had been
used for other semen analysis research, eligibility for this
study was based on availability of a urine and semen sam-
ple in the biorepository. Of the 341 men enrolled in the
parent study, sufficient samples were available for 75
(22%). The parent study was approved by the Harvard
School of Public Health and the MGH Human Subjects
Committees. All subjects signed an informed consent prior
to participation.
Semen analysis
Subjects were asked to abstain from ejaculation for 48 hours
prior to providing a semen sample at the clinic via mastur-
bation. Samples were liquefied at 37ºC for 20 minutes be-
fore analysis. Analysis of the samples took place at the
MGH Andrology Laboratory with andrologists blindedto exposure status. The volume, pH, color, and viscosity
were determined for each sample. Measurement of the
semen parameters has been previously described [24].
Sperm counts and percent motility were determined
manually and then measured by computer-aided sperm
analysis (CASA) using the Hamilton-Thorn Motility
Analyzer (10HTM-IVO; Hamilton Thorne Inc., Beverly,
MA, USA). A minimum of 200 sperm from 4 different
fields were analyzed. Each sample was also prepared on two
slides for morphological assessment using a Nikon micro-
scope with an oil immersion 100x objective (Nikon Com-
pany, Tokyo, Japan). Sperm were scored using Tygerberg
Strict criteria [25].
Disomy analysis
Fluorescence in situ hybridization (FISH) analysis for the
detection of sex chromosome disomy was performed by
a single investigator blinded to exposure status. The pro-
cedures for this analysis have been described elsewhere
[26]. Briefly, the FISH procedure was carried out for three
chromosomes of interest: X, Y and 18 (autosomal control).
While sex chromosome disomy (XX18, XY18, and YY18)
was the primary outcome of interest, data were also col-
lected on the frequency of 1818 disomy. A series of non-
overlapping field images were taken for each prepared FISH
slide using a fluorescence microscope and scored using
custom MATLAB software. The software was designed to
utilize scoring criteria for size and shape as reported by
Baumgartner et al. [27]. A co-localization analysis allowed
the software to identify sperm nuclei and the number of
signals contained therein. The procedures and validation of
this semi-automated scoring method have been reported
previously by Perry et al. [28,29].
Urine analysis
Urine samples were frozen at -20°C and mailed on dry
ice to the Centers for Disease Control and Prevention
Pesticide Laboratory. Analysts were blinded to study objec-
tives and to the individual characteristics of the study sam-
ples. The PYR metabolites 3-phenoxybenzoic acid (3PBA),
cis-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carbox-
ylic acid (CDCCA) and trans-3-(2,2-dichlorovinyl)-2,2-di
methylcyclopropane carboxylic acid (TDCCA) were mea-
sured using a procedure previously described [30]. In
summary, the samples were fortified with stable isotope
analogs of the target analytes, underwent solid phase ex-
traction, and were analyzed using high-performance liquid
chromatography coupled with tandem mass spectrometry
using turbo ion-spray atmospheric pressure ionization.
The limits of detection (LODs) were 0.1 μg/L for 3BPA,
0.23 μ/L for CDCCA and 0.35 μg/L for TDCCA. 3PBA is a
common metabolite of several PYRs including cyhalothrin,
cypermethrin, deltamethrin, fenvalerate and permethrin;
CDCCA and TDCCA are metabolites of cis-permethrin
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rethroids such as cyfluthrin and cypermethrin [31]. Specific
gravity of the urine samples was measured using a hand-
held refractometer (National Instrument Company, Inc.,
Baltimore, MD, USA). Creatinine was measured photomet-
rically using kinetic colorimetric assay technology with a
Hitachi 911 automated chemistry analyzer (Roche Diag-
nostics, Indianapolis, IN, USA).
Statistical analysis
Descriptive statistics for demographic and semen param-
eters were summarized using frequency distributions or
means and standard deviations as appropriate. Semen
parameters were dichotomized using the World Health
Organization reference values for sperm concentration
(<20 million sperm/mL) and motility (<50% motile sperm)
and the Tygerberg Strict Criteria for morphology (<4%
normal morphology) [25,32]. Due to the relatively low
proportion and limited distribution of values above the
LOD, pyrethroid metabolite concentrations were catego-
rized as above and below the limit of detection (LOD).
When the instrument did not detect an analyte in the
sample, an imputed value equal to one-half the LOD was
used. In some instances, samples with metabolite values
below the LOD were detected by the machine. For these
samples, the actual machine reading was used. Descriptive
statistics for metabolites and disomy data were summa-
rized as mean and standard deviation, geometric mean,
median, and relevant percentiles.
Creatinine concentrations are commonly used to ad-
just for urine dilution, but some studies have shown that
creatinine adjustment may not be appropriate for some
organic compounds that can be conjugated by the liver
[33]. Creatinine levels also vary by a number of other
personal factors including sex [34,35]; age [36,37]; de-
creasing muscle mass [38,39]; diet [40]; and time of day
or seasonality [41,42], so adjusting urine metabolite con-
centrations using specific gravity may be more appropriate
[43]. Creatinine and specific gravity adjusted summaries as
well as volume-based (unadjusted) values are presented.
Due to the large number of sperm being scored and
the relatively low frequency of disomy, Poisson regres-
sion (SAS GENMOD procedure) was utilized to model
the association between each of the disomy measures
and the individual volume-based metabolite values in
unadjusted and adjusted analyses. Histograms for all out-
come variables were examined, and all displayed the shape
of a classic Poisson distribution. The number of sperm
scored and the number of disomic nuclei identified were
summed for each subject with the unit of analysis as the
individual subject. This approach offers the advantage that
the use of the offset variable will standardize the number
of sperm counted for each subject. The Poisson model
was fitted using a disomy measure as a count of disomiccells (XX18, YY18, XY18, 1818, and total sex chromosome
disomy) as the outcome variable, the natural logarithm of
the number of sperm counted as the offset variable, the
metabolite of interest as the independent variable along
with age, smoking status, motility, log of sperm concentra-
tion, and specific gravity as covariates in the adjusted ana-
lyses The distribution of sperm concentration is typically
non-normal and markedly positively skewed; therefore,
log transformation is commonly used to deal with sperm
concentration [44]. Age, motility, log of sperm concen-
tration, and specific gravity were included as continuous
variables, and smoking as never, former, and current.
Abstinence time and morphology were also investigated
as covariates but neither were significant predictors of
disomy and did not alter the relationship between me-
tabolites and disomy so they were excluded from the
models. Metabolites were entered into the model as di-
chotomous variables categorized as above and below the
LOD. Incidence rate ratios (IRRs) and 95% confidence
intervals were calculated for each model. Because of con-
cern that samples with creatinine concentrations >300 mg/
dL or <30 mg/dL or specific gravity >1.03 or <1.01 may be
too concentrated or too dilute to provide valid results [45],
a sensitivity analysis was performed excluding these indi-
viduals. A sensitivity analysis was also performed excluding
those individuals with fewer than 1000 nuclei scored. Stat-
istical analysis was performed using SAS version 9.2 (SAS
Institute Inc, Cary, NC).
Results
Table 1 shows the demographic and semen parameter
characteristics of the 75 study subjects. The men had an
average age of 35.3 years and a mean BMI of 27.9 kg/m2.
The majority of the men were white (90%) and non-
Hispanic (96%). Most of the men (77%) had never smoked
with only 4% (n = 3) current smokers. Of the 75 men, 11%
(n = 8) had sperm concentrations <20 million/mL, 43%
(n = 32) had <50% motile sperm, and 7% (n = 5) had <4%
normally shaped sperm.
Table 2 provides a summary of the semen disomy re-
sults. A median of 6146 sperm nuclei were scored per
subject. The observed median percentages of XX18, XY18,
YY18, 1818, and total disomy were 0.3, 0.8, 0.3, 0.04, and
1.5 respectively.
Table 3 summarizes the unadjusted urinary pyrethroid
metabolite as well as the specific gravity and creatinine
adjusted concentrations. Of the 75 samples, 56% (n = 42)
were above the LOD for 3PBA, 29% (n = 22) were above
the LOD for CDCCA, and 25% (n = 19) were above the
LOD for TDCCA. Although the percentage above LOD
was higher for 3PBA, the median levels were slightly
higher for TDCCA. The specific gravity and creatinine
adjusted results were similar. All three pyrethroid me-
tabolites were highly correlated (r = 0.92-0.97).
Table 1 Characteristics of the study population men (n = 75)
Variable Mean ± SD
Age 35.3 ± 5.1
BMI (kg/m2) 27.9 ± 4.8
Semen concentration (in millions/mL) 110.1 ± 104.8
Semen motility (%) 54.2 ± 22.2
Semen morphology (% normal) 8.5 ± 3.8
Race (n = 2 missing) N (%)
White 66 (90.4)
Black 2 (2.7)
Other 5 (6.9)
Hispanic ethnicity
No 72 (96.0)
Yes 3 (4.0)
Semen concentration
<20 million/mL 8 (11.0)
Semen morphology
<4% normal 5 (7.0)
Semen motility
<50% motile 32 (42.7)
Abstinence time
< = 2 days 19 (25.3)
3-4 days 36 (48.0)
> = 5 days 20 (26.7)
Smoking (n = 2 missing)
No 56 (76.7)
Current smoker 3 (4.1)
Former smoker 14 (19.2)
SD = Standard deviation.
BMI-Body Mass Index.
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evaluated disomies as well as total disomy stratified by
detectable levels of pyrethroid metabolites. Table 5 pro-
vides the results of the Poisson regression models for each
outcome adjusted for age, specific gravity and smokingTable 2 Number of nuclei scored and aneuploidy (n = 75)
Variable Mean ± SD Median 25th
percentile
75th
percentile
Nuclei (n) 7073 ± 4536 6146 3438 10,291
% X18 38.8 ± 8.4 41.4 34.2 45.1
% Y18 37.3 ± 9.2 40.4 33.4 43.5
% XX18 0.47 ± 0.49 0.31 0.18 0.57
% YY18 0.36 ± 0.30 0.28 0.19 0.43
% XY18 1.09 ± 0.76 0.83 0.58 1.43
% 1818 0.04 ± 0.03 0.04 0.02 0.06
Total Disomy % 1.92 ± 1.18 1.53 1.13 2.54
SD = Standard deviation.when categorizing the metabolites was examined as above
and below the LOD. CDCCA and TDCCA showed similar
results when comparing rates of aneuploidy in those men
above the LOD to those men below the LOD. The rates
were increased by 7% to 30% across the aneuploidy out-
comes with the highest risk seen for TDCCA and XX18
(IRR = 1.30; 95% CI: 1.17, 1.46) and the lowest risk seen
for TDCCA and XY18 (IRR = 1.07; 95% CI: 1.00, 1.14) and
no association with 1818. When comparing men with
3PBA concentrations above the LOD to those below the
LOD, rates of YY18 disomy were 1.28 times higher (95%
CI: 1.15, 1.42), whereas a lower rate (IRR = 0.82; 95% CI:
0.77, 0.87) was seen for XY18 and total disomy (IRR =
0.93; 95% CI: 0.87, 0.97). No association was observed be-
tween 3BPA and XX18 or 1818 disomy.
Sensitivity analyses excluding individuals with creatin-
ine concentrations >300 mg/dL or <30 mg/dL, specific
gravity >1.03 or <1.01, or <1000 nuclei scored showed simi-
lar results (data not shown). To examine nonlinear relation-
ships between the outcome and the predictor, generalized
additive models with various types of spline smoothing
were examined with no resulting improvement in model fit.
Discussion
To our knowledge, this is the first study to evaluate as-
sociations between urinary PYR metabolites and human
sperm disomy. Our results showed consistent increased
risks ranging between 7-30% of XX, YY, XY, and total
sex chromosome disomy among those with higher levels
of PYR metabolites (CDCCA and TDCCA) after adjust-
ment for potential confounders. The third metabolite
(3PBA) also displayed a 28% increased risk for YY di-
somy, whereas there was a 16% decrease in the rate of
XY disomy and a 7% decrease in total disomy.
One prior study investigated associations between am-
bient levels of the PYR fenvalerate among workers in a
pesticide manufacturing plant and found significant in-
creases in sex chromosome disomy in exposed workers
(0.74%) compared to an internal (0.56%) and external
(0.39%) control group [45]. The frequency of chromosome
18 disomy was also significantly higher in the exposed
compared to the control groups (0.33%, 0.20%, and 0.12%
respectively) [46]. Although the Xia et al. [46] study exam-
ined an occupationally exposed cohort of men and used
air monitoring for exposure assessment, the magnitude of
increased rates of chromosome disomies associated with
PYR exposure are similar to the increases reported in our
clinic-based sample of men whose main route of exposure
was environmental. The distributions of PYR metabolite
levels in the present study are comparable to those
sampled from males in the National Health and Nutri-
tion Examination Study (NHANES) 2001–2002 [17].
Unadjusted CDCCA and TDCCA concentrations were
similar in the current study with median values below
Table 3 Distribution of pyrethroid metabolite levels (μg/L) in urine (n = 75)
Metabolite Mean ± SD Geometric mean 25% Median 75% 90% Range
Unadjusted
3PBA 0.57 ± 1.27 0.18 0.05 0.15 0.51 1.04 0.01-7.90
CDCCA 0.32 ± 0.72 0.12 0.06 0.12 0.25 0.56 0.001-4.30
TDCCA 0.64 ± 1.61 0.18 0.09 0.18 0.46 1.13 0.001-10.84
Specific gravity adjusted
3PBA 0.65 ± 1.34 0.24 0.09 0.22 0.63 1.29 0.01-8.28
CDCCA 0.72 ± 1.73 0.15 0.07 0.15 0.33 0.57 0.001-5.25
TDCCA 0.38 ± 0.83 0.23 0.12 0.21 0.53 1.13 0.001-11.36
Creatinine adjusted (μg/g creatinine)
3PBA 0.50 ± 1.24 0.15 0.06 0.11 0.36 0.94 0.009-7.77
CDCCA 0.30 ± 0.90 0.10 0.04 0.09 0.20 0.37 0.001-6.84
TDCCA 0.56 ± 1.63 0.14 0.07 0.13 0.34 0.90 0.001-10.33
SD = Standard deviation.
3PBA = 3-phenoxybenzoic acid; LOD = 0.10 μg/L.
CDCCA = cis-dichlorovinyl-dimethylcyclopropane carboxylic acid; LOD = 0.23 μg/L.
TDCCA = trans-dichlorovinyl-dimethylcyclopropane carboxylic acid; LOD = 0.35 μg/L.
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percentiles of 0.56 and 1.13 μg/L respectively, compared to
0.47 and 1.09 μg/L from NHANES 2001–2002. Unadjusted
median and 90th percentiles for 3PBA were lower for the
current study (0.15 and 1.04 μg/L respectively) compared
to 0.30 and 1.55 μg/L from NHANES 2001–2002.
PYRs and their metabolites have been identified in
multiple environmental media, including soil, aquatic or-
ganisms [47], sediment [48], and residues in food [49].
PYRs have also been detected in breast milk [50]. While
there is a large body of literature on pyrethroid toxicology,
not all biological effects and clinical signs and symptoms
are completely understood, particularly in humans [51].
There is evidence from human reporter gene assays dem-
onstrating the ability of PYRs to bind with and disruptTable 4 Aneuploidy Mean ± SD by detection of pyrethroid me
%XX18 %YY18
3PBA
≤LOD (n = 33) 0.44 ± 0.31 0.32 ± 0.81
>LOD (n = 42) 0.49 ± 0.60 0.40 ± 0.37
CDCCA
≤LOD (n = 53) 0.46 ± 0.49 0.38 ± 0.33
>LOD (n = 22) 0.50 ± 0.51 0.33 ± 0.23
TDCCA
≤LOD (n = 56) 0.44 ± 0.48 0.37 ± 0.33
>LOD (n = 19) 0.56 ± 0.52 0.35 ± 0.23
SD = Standard deviation.
LOD = Limit of detection.
3PBA = 3-phenoxybenzoic acid; LOD = 0.10 μg/L.
CDCCA = cis-dichlorovinyl-dimethylcyclopropane carboxylic acid; LOD = 0.23 μg/L.
TDCCA = trans-dichlorovinyl-dimethylcyclopropane carboxylic acid; LOD = 0.35 μg/L.androgen receptors [52,53], and results from epidemio-
logical studies suggest environmental exposure to pyre-
throids is associated with changes in thyroid and sex
hormone levels in men [54,55]. Because of their endocrine
disrupting properties, the initial list of 67 chemicals being
screened by the United States Environmental Protection
Agency (USEPA) through its Endocrine Disruptor Screen-
ing Program includes six PYRs, selected based on their ex-
posure potential. Binding to xenobiotic-sensing nuclear
receptors, such as Pregnane X receptor (PXR), has also
been documented [56]. PXR expression is found primarily
in the liver, with some expression in testis and embryonic
tissues in humans [57].
PYRs affect estrogen receptors in Sertoli cells [58] and
some PYR forms appear to exert antiandrogenic effectstabolite levels (n = 75)
%XY18 %1818 Total disomy %
1.14 ± 0.81 0.05 ± .0.03 1.90 ± 1.04
1.04 ± 0.72 0.04 ± 0.03 1.93 ± 1.28
1.05 ± 0.80 0.05 ± 0.03 1.88 ± 1.23
1.18 ± 0.67 0.03 ± 0.03 2.00 ± 1.05
1.05 ± 0.80 0.05 ± 0.03 1.85 ± 1.23
1.20 ± 0.62 0.04 ± 0.03 2.11 ± 1.00
Table 5 Adjusteda IRRs (95% CI) for XX, YY, XY, 1818, and total sex-chromosome disomy for pyrethroid metabolite
levels above versus below the LOD
XX18 YY18 XY18 1818 Total Disomy
3PBA
≤LOD (n = 33) 1.00 1.00 1.00 1.00 1.00
>LOD (n = 42) 1.00 (0.90, 1.10) 1.28 (1.15, 1.42) 0.82 (0.77, 0.87) 0.89 (0.65, 1.23) 0.93 (0.87, 0.97)
CDCCA
≤LOD (n = 53) 1.00 1.00 1.00 1.00 1.00
>LOD (n = 22) 1.22 (1.09, 1.36) 1.18 (1.05, 1.31) 1.07 (1.00, 1.14) 0.89 (0.65, 1.21) 1.12 (1.06, 1.17)
TDCCA
≤LOD (n = 56) 1.00 1.00 1.00 1.00 1.00
>LOD (n = 19) 1.30 (1.17, 1.46) 1.19 (1.06, 1.34) 1.01 (0.93, 1.08) 1.10 (0.84, 1.44) 1.09 (1.04, 1.15)
IRRs = Incidence rate ratios.
CI = Confidence interval.
LOD = Limit of detection.
3PBA = 3-phenoxybenzoic acid; LOD = 0.10 μg/L.
CDCCA = cis-dichlorovinyl-dimethylcyclopropane carboxylic acid; LOD = 0.23 μg/L.
TDCCA = trans-dichlorovinyl-dimethylcyclopropane carboxylic acid; LOD = 0.35 μg/L.
aAdjusted for specific gravity, age, smoking, motility, and log of sperm concentration.
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inal vesicle weight [59]. Because pyrethroids are manu-
factured to kill target insects by affecting ion channel
function, their actions on the activation and inactivation
of voltage-gated sodium channels (VGSCs) and neuronal
excitability are well understood, but less is known about
pyrethroid effects on other target organs such as the testis
[11,60]. Importantly, voltage gated sodium channels are
present in human sperm and they have a role in support-
ing the regulation of motility [61]. Several animal studies
show links between PYR exposures and sperm function,
including sperm capacitation and semen quality [62] and
sperm motility [63]. One study reported dose and time
dependent effects of cyhalothrin exposure on structural
and numerical chromosomal damage in primary sper-
matocytes in mice [64]. Whether VGSCs in sperm play a
role in meiotic signaling that can affect nondisjunction re-
quires investigation, as it could be the biological mechan-
ism underlying the associations reported here.
Independent of the parent compound activities, evi-
dence from in-vitro yeast assays suggests that CDCCA,
TDCCA and 3PBA have anti-estrogenic activities and
that 3-phenoxybenozic alcohol, a metabolic precursor to
3PBA, has anti-androgenic activity [14]. Additionally,
3PBA has been shown to have anti-androgenic activity
in reporter gene assays [52,53]. Androgen suppression in
rats has been demonstrated to affect the expression of a
number of proteins involved in cell division in male germ
cells [65]. Changes in the expression of these proteins and
how they impact the incidence of sex chromosome disomy
requires further study. There may be differences in the be-
haviors of individual pyrethroid metabolites that result in
unknown enzymatic or proteomic impacts, including vary-
ing effects on the signaling for meiotic controls. In thisstudy, the differences in the metabolic products that result
in 3PBA may account for the observation that 3PBA was
associated with an increase in YY disomy frequency and a
decrease in XY disomy. Perhaps 3PBA or one of its pre-
cursors alters the activities of critical meiotic proteins that
regulate the separation of chromosomes and chromatids.
Further research into the potential influences of pyre-
throids or their metabolites on meiotic control mecha-
nisms is needed to better explain these findings.
There are limitations to the use of non-persistent pesti-
cide exposure biomarkers. The metabolites measured in
this study are not specific to a single pesticide. The correla-
tions among the pyrethroid metabolites were high, making
it difficult to distinguish possible mechanistic groupings.
Biomonitoring of insecticide concentrations in urine is
commonly used as an indicator of internal dose; however
PYRs are rapidly metabolized and excreted [66] and a sin-
gle urine analysis is not likely to be as robust as multiple
measures in representing longer term exposure. Given that
spermatogenesis occurs over approximately sixty days [67]
and meiosis approximately occurs in the middle of the
cycle, determining if exposure was present pre-meiosis is
important to link exposures to errors causing nondisjunc-
tion. A prior study by Meeker et al. [68] showed that a
single urine sample was reasonably predictive of levels
over a three month average for metabolites of other
non-persistent pesticides.
The men in this study were from a fertility clinic as
opposed to the general population. For this to limit the
external validity of these findings, the men who visited the
fertility clinic would need to differ from men in the gen-
eral population in a way that would alter response to
PYRs, for which there does not appear to be evidence.
While the men were members of subfertile couples
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motility and approximately 90% had normal concentration
and morphology.
Disomy frequencies in the current study are higher
than in the prior occupational pyrethroid exposure study
[46], as well as higher than previously reported ranges
[69,70]. These studies did not include men seeking fertil-
ity consultation. A validated semi-automated method for
disomy frequency determination was used in this study,
whereas most prior studies have used manual scoring.
One recent study among andrology clinic patients using
automated methods found higher disomy rates than previ-
ously reported, with total sex chromosome disomy aver-
aging between 1.3-1.5% total disomy; however, they found
no differences between manual and automated estimates
[71]. Our validation studies comparing automated to
manual results for sex chromosome disomy in normo-
zoospermic men from a fertility clinic found higher di-
somy estimates than previously reported in non-clinic
studies, but results did not differ between manual and
semi-automated methods [28,29]. Use of a validated semi-
automated method for counting disomic sperm in this
study was considered a methodological strength because it
allowed for objective and reliable processing of a large
number of samples.
Most causes of male factor infertility are unknown, but
environmental exposures have been suspected as risk fac-
tors. Epidemiological studies have suggested an increased
risk of aneuploidy associated with environmental expo-
sures. The results reported here are preliminary in impli-
cating PYRs as sperm aneugens, but point to the need to
further study environmental exposures as risk factors for
male factor infertility. Given that these exposures are wide-
spread, questions remain as to what effects they might be
having on population reproductive health.Conclusions
The results from this study suggest that men with de-
tectable urinary concentrations of CDCCA and TDCCA
have significant increases in almost all sex chromosome
disomies compared to men with non-detectable urinary
concentrations of CDCCA and TDCCA. Men with urin-
ary concentrations of 3PBA above the limit of detection
also have significantly increased rates of YY disomy, but
have significantly reduced rates of XY and total disomy.
This study was unable to determine how or why the ef-
fects of exposure would differ between the various sex
chromosome disomy outcomes and across related PYR
metabolites. This is the first epidemiologic study to
examine the relationship between environmental expos-
ure to pyrethroids and sperm sex chromosome disomy
so findings require replication in future studies and in
other populations.Abbreviations
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